When does a difference make a difference? Interpretation of number needed to treat, number needed to harm, and likelihood to be helped or harmed

International Journal of Clinical Practice

Volumn 67, Issue 5, 2013, Pages 407-411

  Citrome, L ^a   Ketter, T A ^b  

^a NEW YORK MEDICAL COLLEGE   (United States)

^b STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHYPERTENSIVE AGENT; DULOXETINE; LOXAPINE; LURASIDONE; OLANZAPINE; PLACEBO; VILAZODONE;

ADVERSE OUTCOME; CALCULATION; DEPRESSION; HEALTH HAZARD; HUMAN; HYPERTENSION; LIKELIHOOD TO BE HARMED; LIKELIHOOD TO BE HELPED; MAJOR DEPRESSION; MEDICAL LITERATURE; NAUSEA; NUMBER NEEDED TO HARM; NUMBERS NEEDED TO TREAT; PARKINSONISM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; RISK BENEFIT ANALYSIS; SCHIZOPHRENIA; SIDE EFFECT; STATISTICAL ANALYSIS; TIME; TREATMENT RESPONSE; WEIGHT GAIN;

CLINICAL TRIALS AS TOPIC; HARM REDUCTION; HUMANS; NUMBERS NEEDED TO TREAT; REFERENCE VALUES; RISK ASSESSMENT; TREATMENT OUTCOME;

EID: 84876475573     PISSN: 13685031     EISSN: 17421241     Source Type: Journal    
DOI: 10.1111/ijcp.12142     Document Type: Review

References (15)

1. Citrome L,. Compelling or irrelevant? Using number needed to treat can help decide. Acta Psychiatr Scand 2008; 117: 412-9. (Pubitemid 351678479)
2. Citrome L,. Relative vs. absolute measures of benefit and risk: what's the difference? Acta Psychiatr Scand 2010; 121: 94-102.
3. Citrome L,. Quantifying risk: the role of absolute and relative measures in interpreting risk of adverse reactions from product labels of antipsychotic medications. Curr Drug Saf 2009; 4: 229-37.
4. Citrome L, Kantrowitz J,. Antipsychotics for the treatment of schizophrenia: likelihood to be helped or harmed, understanding proximal and distal benefits and risks. Expert Rev Neurother 2008; 8: 1079-91. (Pubitemid 351962075)
5. Ketter TA, Citrome L, Wang PW, Culver JL, Srivastava S,. Treatments for bipolar disorder: can number needed to treat/harm help inform clinical decisions? Acta Psychiatr Scand 2011; 123: 175-89.
6. Srivastava S, Ketter TA,. Clinical relevance of treatments for acute bipolar disorder: balancing therapeutic and adverse effects. Clin Ther 2011; 33: B40-8.
7. Citrome L,. Adjunctive aripiprazole, olanzapine, or quetiapine for major depressive disorder: an analysis of number needed to treat, number needed to harm, and likelihood to be helped or harmed. Postgrad Med 2010; 122: 39-48.
8. Citrome L,. Lurasidone for the acute treatment of adults with schizophrenia: what is the number needed to treat, number needed to harm, and likelihood to be helped or harmed? Clin Schizophr Relat Psychoses 2012; 6: 76-85.
9. Citrome L,. Vilazodone for major depressive disorder: a systematic review of the efficacy and safety profile for this newly approved antidepressant-what is the number needed to treat, number needed to harm and likelihood to be helped or harmed? Int J Clin Pract 2012; 66: 356-68.
10. Citrome L,. Inhaled loxapine for agitation revisited: focus on effect sizes from 2 Phase III randomised controlled trials in persons with schizophrenia or bipolar disorder. Int J Clin Pract 2012; 66: 318-25.
11. Cookson J, Gilaberte I, Desaiah D, Kajdasz DK,. Treatment benefits of duloxetine in major depressive disorder as assessed by number needed to treat. Int Clin Psychopharmacol 2006; 21: 267-73. (Pubitemid 44162478)
12. A'Court C,. 10-minute consultation. Newly diagnosed hypertension. BMJ 2002; 324: 1375. (Pubitemid 34628012)
13. Kraemer HC, Kupfer DJ,. Size of treatment effects and their importance to clinical research and practice. Biol Psychiatry 2006; 59: 990-6. (Pubitemid 43849650)
14. Zimmerman M, Martinez JA, Attiullah N, et al. Why do some depressed outpatients who are in remission according to the Hamilton Depression Rating Scale not consider themselves to be in remission? J Clin Psychiatry 2012; 73: 790-5.
15. Copay AG, Subach BR, Glassman SD, Polly DW Jr, Schuler TC,. Understanding the minimum clinically important difference: a review of concepts and methods. Spine J 2007; 7: 541-6. (Pubitemid 47471437)